Found: 74
Select item for more details and to access through your institution.
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00998-9
- By:
- Publication type:
- Article
New insights into role of microenvironment in multiple myeloma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Toxoplasma pneumonia: Cytologic diagnosis by bronchoalveolar lavage.
- Published in:
- Diagnostic Cytopathology, 1994, v. 11, n. 1, p. 52, doi. 10.1002/dc.2840110112
- By:
- Publication type:
- Article
Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 2, p. 182, doi. 10.1002/ijc.2910510204
- By:
- Publication type:
- Article
Excessive Zinc Ingestion.
- Published in:
- JAMA: Journal of the American Medical Association, 1990, v. 264, n. 11, p. 1441, doi. 10.1001/jama.1990.03450110087033
- By:
- Publication type:
- Article
Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 1, p. 87, doi. 10.1111/bjh.14199
- By:
- Publication type:
- Article
Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma.
- Published in:
- British Journal of Haematology, 2016, v. 174, n. 4, p. 536, doi. 10.1111/bjh.14081
- By:
- Publication type:
- Article
Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of the spectra Optia® mononuclear cell collection procedure in multiple myeloma patients.
- Published in:
- Journal of Clinical Apheresis, 2015, v. 30, n. 1, p. 1, doi. 10.1002/jca.21341
- By:
- Publication type:
- Article
Second primary malignancies after tandem autologous hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2222, doi. 10.1002/ajh.27452
- By:
- Publication type:
- Article
Persistent bone marrow minimal residual disease as a "high‐risk" disease feature in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E341, doi. 10.1002/ajh.26255
- By:
- Publication type:
- Article
CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0005-2
- By:
- Publication type:
- Article
CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0005-2
- By:
- Publication type:
- Article
Expression of leukocyte common antigen in lymphoblastic lymphoma and small noncleaved undifferentiated non-Burkitt's lymphoma: An immunohistochemical study.
- Published in:
- Journal of Pathology, 1987, v. 151, n. 4, p. 257, doi. 10.1002/path.1711510404
- By:
- Publication type:
- Article
Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2228877, doi. 10.1001/jamanetworkopen.2022.28877
- By:
- Publication type:
- Article
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1116, doi. 10.3390/cancers16061116
- By:
- Publication type:
- Article
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4019, doi. 10.3390/cancers13164019
- By:
- Publication type:
- Article
Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 517, doi. 10.3390/cancers13030517
- By:
- Publication type:
- Article
Response to Bortezomib and Activation of Osteoblasts in Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 7, n. 2, p. 109
- By:
- Publication type:
- Article
Superior 12-Year Survival After at Least 4-Year Continuous Remission with Tandem Transplantations for Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 6, p. 469
- By:
- Publication type:
- Article
Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.
- Published in:
- 2003
- By:
- Publication type:
- journal article
ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/ Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 228, doi. 10.1016/j.clml.2011.03.006
- By:
- Publication type:
- Article
Alkaline phosphatase variation during carfilzomib treatment is associated with best response in multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 6, p. 484, doi. 10.1111/j.1600-0609.2011.01602.x
- By:
- Publication type:
- Article
High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.
- Published in:
- 2008
- By:
- Publication type:
- journal article
TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Relapsing polychondritis: A paraneoplastic syndrome associated with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 1992, v. 40, n. 1, p. 47, doi. 10.1002/ajh.2830400110
- By:
- Publication type:
- Article
Religious Struggle and Religious Comfort in Response to Illness: Health Outcomes among Stem Cell Transplant Patients.
- Published in:
- Journal of Behavioral Medicine, 2005, v. 28, n. 4, p. 359, doi. 10.1007/s10865-005-9006-7
- By:
- Publication type:
- Article
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e21, doi. 10.1016/j.clml.2019.09.031
- By:
- Publication type:
- Article
Pregnancy-associated aplastic anemia -Report of 3 cases.
- Published in:
- European Journal of Haematology, 1991, v. 47, n. 4, p. 253, doi. 10.1111/j.1600-0609.1991.tb01567.x
- By:
- Publication type:
- Article
Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.
- Published in:
- Immunologic Research, 2014, v. 59, n. 1-3, p. 188, doi. 10.1007/s12026-014-8528-x
- By:
- Publication type:
- Article
A gene signature can predict risk of MGUS progressing to multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01472-y
- By:
- Publication type:
- Article
Thrombophilia.
- Published in:
- Drug Target Insights, 2008, n. 3, p. 87, doi. 10.4137/DTI.S568
- By:
- Publication type:
- Article
Genomic instability in multiple myeloma: Evidence for jumping segmental duplications of chromosome arm 1q.
- Published in:
- Genes, Chromosomes & Cancer, 2005, v. 42, n. 1, p. 95, doi. 10.1002/gcc.20109
- By:
- Publication type:
- Article
Response to bortezomib in refractory type I cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2008, v. 83, n. 11, p. 883, doi. 10.1002/ajh.21258
- By:
- Publication type:
- Article
Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 9, p. 831, doi. 10.1002/ajh.20961
- By:
- Publication type:
- Article
Hyperammonemia and encephalopathy in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 5, p. 414, doi. 10.1002/ajh.20808
- By:
- Publication type:
- Article
NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0392-4
- By:
- Publication type:
- Article
Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 5, p. 554, doi. 10.1111/j.1365-2141.2010.08286.x
- By:
- Publication type:
- Article
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 5, p. 641, doi. 10.1111/j.1365-2141.2008.07340.x
- By:
- Publication type:
- Article
Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2.
- Published in:
- British Journal of Haematology, 2008, v. 140, n. 6, p. 625, doi. 10.1111/j.1365-2141.2007.06921.x
- By:
- Publication type:
- Article
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.
- Published in:
- British Journal of Haematology, 2007, v. 138, n. 2, p. 176, doi. 10.1111/j.1365-2141.2007.06639.x
- By:
- Publication type:
- Article
Long-term outcome results of the first tandem autotransplant trial for multiple myeloma.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 2, p. 158, doi. 10.1111/j.1365-2141.2006.06271.x
- By:
- Publication type:
- Article
Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 4, p. 399, doi. 10.1111/j.1365-2141.2006.06208.x
- By:
- Publication type:
- Article
Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2005, v. 131, n. 1, p. 71, doi. 10.1111/j.1365-2141.2005.05733.x
- By:
- Publication type:
- Article
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 5, p. 715, doi. 10.1111/j.1365-2141.2004.05078.x
- By:
- Publication type:
- Article
annotation Treatment advances in multiple myeloma.
- Published in:
- 2004
- By:
- Publication type:
- Other